MRNA

Moderna, Inc. Common Stock

$226.30

Current Price

All

AI analysis

Read what the AI thinks of Moderna, Inc. Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$7.98

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Before the open · Expected EPS: -$1.30

Oct 29

Posts

No posts about MRNA yet.

About Moderna, Inc. Common Stock

Moderna is a biotechnology company that pioneered messenger RNA, or mRNA, technology to make vaccines and medicines. It earns most of its money selling its COVID-19 vaccine, Spikevax, to governments and health systems worldwide, and it is now expanding into other shots, including one for RSV, plus experimental cancer treatments it is developing with partner Merck.